Financial reports
ARS
2023 FY
Annual report to shareholders
2 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
6 Apr 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12 Apr 24
8-K
Entry into a Material Definitive Agreement
1 Apr 24
8-K
Other Events
28 Mar 24
8-K
Other Events
27 Mar 24
8-K
Departure of Directors or Certain Officers
4 Mar 24
8-K
Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus Technology
21 Feb 24
8-K
Vaccinex, Inc. Announces Reverse Stock Split
15 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
13 Feb 24
8-K/A
Financial Statements and Exhibits
8 Feb 24
8-K
Entry into a Material Definitive Agreement
7 Feb 24
Registration and prospectus
424B3
Prospectus supplement
16 Apr 24
D
$2.46 mm in equity / options / securities to be acquired, sold $1.24 mm, 3 investors
12 Apr 24
D
$3.50 mm in equity / options / securities to be acquired, sold $1.75 mm, 1 investor
12 Apr 24
D
$1.47 mm in options / securities to be acquired, 4 investors
12 Apr 24
S-3
Shelf registration
2 Apr 24
424B5
Prospectus supplement for primary offering
28 Mar 24
424B3
Prospectus supplement
19 Jan 24
S-3
Shelf registration
10 Jan 24
424B4
Prospectus supplement with pricing info
2 Oct 23
S-1MEF
Registration of additional securities for an S-1
28 Sep 23
Proxies
DEF 14A
Definitive proxy
2 Apr 24
DEF 14A
Definitive proxy
8 Jan 24
PRE 14A
Preliminary proxy
28 Dec 23
DEF 14A
Definitive proxy
14 Aug 23
PRE 14A
Preliminary proxy
4 Aug 23
DEF 14A
Definitive proxy
6 Apr 23
DEF 14A
Definitive proxy
5 Apr 22
DEF 14A
Definitive proxy
6 Apr 21
DEF 14A
Definitive proxy
8 Apr 20
DEF 14A
Definitive proxy
9 Apr 19
Other
EFFECT
Notice of effectiveness
17 Apr 24
EFFECT
Notice of effectiveness
22 Jan 24
CORRESP
Correspondence with SEC
17 Jan 24
UPLOAD
Letter from SEC
16 Jan 24
EFFECT
Notice of effectiveness
29 Sep 23
CORRESP
Correspondence with SEC
26 Sep 23
CORRESP
Correspondence with SEC
26 Sep 23
UPLOAD
Letter from SEC
20 Sep 23
EFFECT
Notice of effectiveness
11 Jul 23
CORRESP
Correspondence with SEC
7 Jul 23
Ownership